The forecast for antibacterial medicine use in South Korea shows a consistent decline from 2024 to 2028. The defined daily dosage per thousand persons per day is projected to be 23.2 in 2024, decreasing to 19.5 by 2028. This indicates a year-on-year percentage decrease, reflecting a continual reduction in the use of antibacterial medicines. In comparison with the actual use in 2023, which stood higher than 23.2, the decreasing trend is clear.

Year-on-Year Variations:

2024: 23.2
2025: -4.7%
2026: -4.1%
2027: -4.2%
2028: -4.0%

Over the last two years, the antibacterial medicine use has reduced consistently. The Compound Annual Growth Rate (CAGR) for the projected period is -4.3%, showcasing an average annual reduction.

Future trends to watch for include changes in public health policies, the impact of increased awareness and education on antibiotic resistance, and advancements in alternative treatments. Monitoring these factors will be crucial to understanding and anticipating further shifts in antibacterial medicine usage.

Download as XLS

More about Antiviral Industry 2026-2030